These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22401741)

  • 1. Latent tuberculosis in rheumatoid arthritis: evaluating cellular response and high-resolution computed tomography.
    Tannus Silva DG; Silva BD; Torres PP; Santana PJ; Junqueira-Kipnis AP; Rabahi MF
    Arch Bronconeumol; 2012 May; 48(5):144-9. PubMed ID: 22401741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TST, QuantiFERON-TB Gold test and T-SPOT.TB test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-TNF therapy.
    Sargın G; Şentürk T; Ceylan E; Telli M; Çildağ S; Doğan H
    Tuberk Toraks; 2018 Jun; 66(2):136-143. PubMed ID: 30246657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.
    Park JH; Seo GY; Lee JS; Kim TH; Yoo DH
    J Rheumatol; 2009 Oct; 36(10):2158-63. PubMed ID: 19723901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.
    Mariette X; Baron G; Tubach F; Lioté F; Combe B; Miceli-Richard C; Flipo RM; Goupille P; Allez M; Salmon D; Emilie D; Carcelain G; Ravaud P
    Ann Rheum Dis; 2012 Nov; 71(11):1783-90. PubMed ID: 22258485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of strategies using new immunological diagnostic tests of latent tuberculosis infection before TNF-blockers therapy.
    Freund R; Granger B; Francois C; Carcelain G; Ravaud P; Mariette X; Fautrel B
    Presse Med; 2018 Feb; 47(2):e9-e13. PubMed ID: 29478790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased detection of latent tuberculosis by tuberculin skin test and booster phenomenon in early rheumatoid arthritis patients.
    Pérez-Barbosa L; Esquivel-Valerio JA; Arana-Guajardo AC; Vega-Morales D; Riega-Torres J; Garza-Elizondo MA
    Rheumatol Int; 2015 Sep; 35(9):1555-9. PubMed ID: 25773658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of interferon gamma release assay & tuberculin skin tests for diagnosis of latent tuberculosis in patients on maintenance haemodialysis.
    Agarwal SK; Singh UB; Zaidi SH; Gupta S; Pandey RM
    Indian J Med Res; 2015 Apr; 141(4):463-8. PubMed ID: 26112848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
    Hsia EC; Schluger N; Cush JJ; Chaisson RE; Matteson EL; Xu S; Beutler A; Doyle MK; Hsu B; Rahman MU
    Arthritis Rheum; 2012 Jul; 64(7):2068-77. PubMed ID: 22238071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for latent tuberculosis infection among patients with rheumatoid arthritis in the era of biologics and targeted synthetic disease-modifying anti-rheumatic drugs in India, a high-burden TB country: The importance of Mantoux and Quantiferon-TB Gold tests.
    Malaviya AN; Aggarwal VK; Rawat R; Baghel S; Thakran R; Zaheer Q; Garg S; Kapoor S
    Int J Rheum Dis; 2018 Aug; 21(8):1563-1571. PubMed ID: 29345081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors.
    Papay P; Primas C; Eser A; Novacek G; Winkler S; Frantal S; Angelberger S; Mikulits A; Dejaco C; Kazemi-Shirazi L; Vogelsang H; Reinisch W
    Aliment Pharmacol Ther; 2012 Nov; 36(9):858-65. PubMed ID: 22978645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QuantiFERON-TB Gold in the identification of latent tuberculosis infection in rheumatoid arthritis: a pilot study.
    Shovman O; Anouk M; Vinnitsky N; Arad U; Paran D; Litinsky I; Caspi D; Elkayam O
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1427-32. PubMed ID: 19861018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interferon-gamma assays T-SPOT.TB for the diagnosis of latent tuberculosis infection].
    Borkowska D; Zwolska Z; Michałowska-Mitczuk D; Korzeniewska-Koseła M; Zabost A; Napiórkowska A; Kozińska M; Brzezińska S; Augustynowicz-Kopeć E
    Pneumonol Alergol Pol; 2011; 79(4):264-71. PubMed ID: 21678276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing tuberculin skin test and interferon γ release assay (T-SPOT.TB) to diagnose latent tuberculosis infection in household contacts.
    Lee HW; Lee YJ; Kim SJ; Park JS; Cho YJ; Yoon HI; Lee CT; Lee JH
    Korean J Intern Med; 2017 May; 32(3):486-496. PubMed ID: 28111432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis.
    Murakami S; Takeno M; Kirino Y; Kobayashi M; Watanabe R; Kudo M; Ihata A; Ueda A; Ohno S; Watanuki Y; Kaneko T; Ishigatsubo Y
    Tuberculosis (Edinb); 2009 Mar; 89(2):136-41. PubMed ID: 19211305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of a TST and the T-SPOT®.TB assay for latent tuberculosis infection diagnosis before anti-TNF-α treatment.
    Jung YJ; Lyu J; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee KH; Lee SD; Kim WS; Kim DS; Shim TS
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1300-6. PubMed ID: 22863375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
    Costantino F; de Carvalho Bittencourt M; Rat AC; Loeuille D; Dintinger H; Béné MC; Faure G; Chary-Valckenaere I
    J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?
    Soysal A; Toprak D; Koc M; Arikan H; Akoglu E; Bakir M
    Nephrol Dial Transplant; 2012 Apr; 27(4):1645-50. PubMed ID: 21931124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma release assays versus tuberculin skin testing in patients with rheumatoid arthritis.
    Song GG; Bae SC; Lee YH
    Int J Rheum Dis; 2013 Jun; 16(3):279-83. PubMed ID: 23981748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.